These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12947857)

  • 1. Risk factors for chronic graft dysfunction in 918 renal transplants.
    Mota A; Figueiredo A; Macário F; Cunha FX; Freitas L; Parada B; Bastos C; Furtado L
    Transplant Proc; 2003 May; 35(3):1064-5. PubMed ID: 12947857
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors for acute rejection in 806 cyclosporine-treated renal transplants: a multivariate analysis.
    Mota A; Figueiredo A; Cunha MF; Bastos M; Pratas J; Furtado L
    Transplant Proc; 2003 May; 35(3):1061-3. PubMed ID: 12947856
    [No Abstract]   [Full Text] [Related]  

  • 3. Experience with 300 renal transplants in Shiraz, Iran.
    Ahmad E; Malek Hosseini SA; Salahi H; Javid R; Ghahramani N; Nezakatgoo N
    Transplant Proc; 1995 Oct; 27(5):2767. PubMed ID: 7482906
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term survival of cadaveric renal transplantation: a clinical analysis in a local renal transplantation center.
    Li CD; Wen ZL; Yan YR; Cai Y
    Transplant Proc; 1998 Nov; 30(7):3092-3. PubMed ID: 9838364
    [No Abstract]   [Full Text] [Related]  

  • 5. Simple tacrolimus-based immunosuppressive regimens following renal transplantation: a large multicenter comparison between double and triple therapy.
    Pascual J; Ortuño J;
    Transplant Proc; 2002 Feb; 34(1):89-91. PubMed ID: 11959198
    [No Abstract]   [Full Text] [Related]  

  • 6. Kidney transplantation in elderly patients.
    Pretagostini R; Berloco P; Poli L; Rossi M; Caricato M; Casciaro G; Cocciolo P; Colonnello M; Venettoni S; Bruzzone P; Novelli G; Alfani D; Cortesini R
    Transplant Proc; 1996 Feb; 28(1):192-3. PubMed ID: 8644174
    [No Abstract]   [Full Text] [Related]  

  • 7. Nephrotoxicity-free, mycophenolate mofetil-based induction/maintenance immunosuppression in elderly recipients of renal allografts from elderly cadaveric donors.
    Theodorakis J; Schneeberger H; Illner WD; Stangl M; Zanker B; Land W
    Transplant Proc; 2000 Feb; 32(1A Suppl):9S-11S. PubMed ID: 10686311
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of 160 consecutive living unrelated kidney transplants: 1983-1997.
    Alfani D; Pretagostini R; Rossi M; Poli L; De Simone P; Colonnello M; Novelli G; Urbano D; Venettoni S; Persijn G; Smits J; Cortesini R
    Transplant Proc; 1997 Dec; 29(8):3399-401. PubMed ID: 9414764
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of antithymocyte globulin induction treatment on renal transplant outcome.
    Sanchez-Fructuoso AI; Naranjo P; Torrente J; Fernández-Pérez C; Avilés B; Prats D; Barrientos A
    Transplant Proc; 1998 Aug; 30(5):1790-2. PubMed ID: 9723284
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal transplantation in Iran: a single-center study.
    Kayedi M; Golbabaie M; Najafi I; Ganji MR; Naderi GH; Mehraban D; Hakemi M
    Transplant Proc; 2001 Aug; 33(5):2646-7. PubMed ID: 11498104
    [No Abstract]   [Full Text] [Related]  

  • 11. Kidney transplantation from living donors in Hungary: experience of 22 years.
    Perner F; Hidvégi M; Járay J; Alföldy F; Gyódi E; Petrányi G
    Transplant Proc; 1996 Dec; 28(6):3584-90. PubMed ID: 8962389
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term comparison of tacrolimus and cyclosporine-based immunosuppression in kidney recipients with grafts from non-heart-beating cadaver donor.
    Kinukawa T; Ohshima S; Ono Y; Fujita T; Hattori R; Tanaka K
    Transplant Proc; 1998 Jun; 30(4):1227-9. PubMed ID: 9636498
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of acute rejection in chronic rejection.
    Vanrenterghem Y
    Transplant Proc; 1998 Jun; 30(4):1210-1. PubMed ID: 9636491
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term results and risk factors of quadruple immunosuppression in renal transplantation.
    Hiesse C; Kriaa F; Eschwege P; Boubenider S; Marchand S; Benoit G; Charpentier B
    Transplant Proc; 1999; 31(1-2):1111-2. PubMed ID: 10083496
    [No Abstract]   [Full Text] [Related]  

  • 15. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
    Wong KM; Cheung CY; Chan YH; Chak WL; Choi KS; Chau KF; Li CS
    Transplant Proc; 2000 Nov; 32(7):1721-2. PubMed ID: 11119907
    [No Abstract]   [Full Text] [Related]  

  • 16. Kidney transplantation, the Halifax experience.
    Belitsky P; MacDonald AS; Lawen J; McAlister V; Bitter-Suermann H; Kiberd B; West K; Sketris I
    Clin Transpl; 1996; ():231-40. PubMed ID: 9286572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney transplantation in Kermanshah, Iran: a 5-year experience.
    Reissi D; Bardideh A; Samadzadeh B; Razi A
    Transplant Proc; 1995 Oct; 27(5):2765-6. PubMed ID: 7482905
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of proteinuria in cyclosporine-treated cadaveric renal transplant recipients.
    Koay HC; Vathsala A; Woo KT
    Transplant Proc; 2000 Nov; 32(7):1921-3. PubMed ID: 11120001
    [No Abstract]   [Full Text] [Related]  

  • 19. Tacrolimus as a primary immunosuppressive therapy in cadaveric renal transplantation: five years' experience at a single center.
    Schneeberger H; Zanker B; Hillebrand G; Illner WD; Rothenpieler U; Land W
    Transplant Proc; 1998 Jun; 30(4):1598-9. PubMed ID: 9636642
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical factors which influence the long-term survival of kidney allografts donated from haploidentical donors.
    Yasumura T; Oka T; Ohmori Y; Nakane Y; Yoshimura N; Nakai I; Hamashima T
    Transpl Int; 1992; 5 Suppl 1():S153-5. PubMed ID: 14621762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.